@import url("/css/styles.css"); @import url("/css/styles-red.css");
Avlar BioVentures
About Avlar
Management
Active Management
Leaders in Life Sciences
Cambridge Cluster
Presentations
Testimonials
Portfolio Companies
Quoted Companies
PAION
Unquoted Companies
Amura Ltd
Crescendo Biologics
CellCentric Ltd
De Novo Pharmaceuticals
ImmunoBiology Ltd
Medical Device Innovation
Proteom
Purely Proteins
Sold Companies
Paradigm Therapeutics
Cozart plc
Sterix Limited
Cambridge Biotechnology L
Sangamo BioSciences
CeNeS
Portfolio News
For Investors
The Funds
Our Investors
Preferred Advisors
Contact Us
How to find us
You are here:
Homepage
>
Portfolio Companies
>
Quoted Companies
Quoted Portfolio Companies
PAION
Unquoted Portfolio Companies
Amura Ltd
Crescendo Biologics
CellCentric Ltd
De Novo Pharmaceuticals
ImmunoBiology Ltd
Medical Device Innovation
Proteom
Purely Proteins
Sold Companies
Paradigm Therapeutics
Cozart plc
Sterix Limited
Cambridge Biotechnology L
Sangamo BioSciences
CeNeS
Tuesday, February 7, 2012
Quoted Portfolio Companies
PAION AG
Portfolio News
19 December 2011
PAION Announces Restructuring
22 June 2011
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer
17 May 2011
Revenue Sharing and Co-Development Agreement with ERGOMED
All Portfolio News
News Archive
2004
News Archive
Our Investors
3i
Access Capital Partners
Astellas Venture Capital
Avlar management
BTG
Cambridge University
Coller Capital
European Investment Fund
Lloyds TSB DC
Lexington Partners Inc
Preferred Advisors
Covington & Burling LLP
Opportunities
CEOs with relevant experience for start-up / early stage Life Science companies.